Why Drug Reps Are Prescribing Zoom
Bloomberg Businessweek|June 15, 2020
A business that’s long relied on face-to-face sales adopts social distancing in the Covid age
Por Emma Court

In April, just weeks into the coronavirus-prompted shutdowns, Kevin Bordelon, a sales representative for drug giant Sanofi, looked up from a video call with a dermatologist to spot a redheaded blur in the background. It was his 3-year-old toddler, racing in with “nothing but underwear on and peanut butter all over his face,” he recalls, laughing. “And there’s just nothing you can do at that point to stop it, you know? You just kind of let it happen.”

Bordelon’s toddler disruptions while working from home are a far cry from the iconic image of a polished pharmaceutical sales rep barging into a doctor’s office with briefcase and a spread of drug samples in hand—think Jake Gyllenhaal peddling Viagra pills in the 2010 romantic comedy Love & Other Drugs. But the pandemic has changed things, even in the world of sales. The 40-year-old Bordelon used to spend his workdays traveling across the U.S., meeting with doctors and other medical providers. Lately, though, he’s swapped the fieldwork for a home-office setup, virtual meetings, and some rowdy new co-workers: his 3-yearold and 6-year-old sons.

Plenty of professionals around the world have made the shift to telework during the pandemic, but it’s an especially big change for America’s 65,000 pharmaceutical salespeople, who have long relied on personal office visits and events. Stuck at home like everyone else, they’ve turned to emails and virtual meetings. But the new formats have left sales reps struggling, more limited in how many clients they can meet in a day and navigating other fresh obstacles.

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BLOOMBERG BUSINESSWEEKView All

Got a Tax Question? Don't Call the IRS

Customer service has cratered at the short-staffed, underfunded agency

5 mins read
Bloomberg Businessweek
January 10, 2022

Big Hot Sauce Wants More Hot Sauce

McCormick, the 132-year-old prince of pumpkin spice, paragon of tarragon, major-domo of marjoram, has taken over an entirely new category

10+ mins read
Bloomberg Businessweek
January 31, 2022

Cyberwar at the White House

Anne Neuberger and the competition to set Biden’s cybersecurity agenda

7 mins read
Bloomberg Businessweek
January 10, 2022

Covid's Unseen Victims

Extra duties and depleted ranks have pharmacy workers buckling under the pressure

6 mins read
Bloomberg Businessweek
January 31, 2022

Need a Hug?

Speculative assets lead a market selloff, but corporate cash could put a floor under prices

9 mins read
Bloomberg Businessweek
January 31, 2022

It's Tricky

American-born Eileen Gu is the face of China’s winter sports initiative, a sponsor’s dream, and a teenage daredevil who’s being very careful with controversy

10+ mins read
Bloomberg Businessweek
January 31, 2022

Do Niche News Sites Have The Secret to Success?

Spiffy online news outlets are hot again. Every month seems to welcome a new publication built on an established journalist’s existing audience.

2 mins read
Bloomberg Businessweek
January 31, 2022

Peering Behind An 18% Yield

Celsius promises big rewards if you let it hold your crypto. The risks you’re taking aren’t clear

8 mins read
Bloomberg Businessweek
January 31, 2022

Stealthy Healthy

Purveyors of clean food are trying a new tactic: Subterfuge.

5 mins read
Bloomberg Businessweek
January 31, 2022

No place to get sick

In the Mississippi Delta, the stress on hospitals, doctors, and nurses— and patients—just won’t let up

10+ mins read
Bloomberg Businessweek
January 31, 2022